Cited by 34Neuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology ResearchComplement system in diseases

Microglial lipid phosphatase SHIP1 limits complement-mediated synaptic pruning in the healthy developing hippocampus

Open access
Matera, Alessandro, Compagnion, Anne-Claire, Pedicone, Chiara, Kotah, Janssen M., Ivanov, Andranik, Monsorno, Katia, Labouèbe, Gwenaël, Leggio, Loredana +11 more·2025·Immunity

Abstract

The gene inositol polyphosphate-5-phosphatase D (INPP5D), which encodes the lipid phosphatase SH2-containing inositol polyphosphate 5-phosphatase 1 (SHIP1), is associated with the risk of Alzheimer's disease (AD). How it influences microglial function and brain physiology is unclear. Here, we showed that SHIP1 was enriched in early stages of healthy brain development. By combining in vivo loss-of-function approaches and proteomics, we discovered that mice conditionally lacking microglial SHIP1 displayed increased complement and synapse loss in the early postnatal brain. SHIP1-deficient microglia showed altered transcriptional signatures and abnormal synaptic pruning that was dependent on the complement system. Mice exhibited cognitive defects in adulthood only when microglial SHIP1 was depleted early postnatally but not at later stages. Induced pluripotent stem cell (iPSC)-derived microglia lacking SHIP1 also showed increased engulfment of synaptic structures. These findings suggest that SHIP1 is essential for proper microglia-mediated synapse remodeling in the healthy developing brain. Disrupting this process has lasting behavioral effects and may be linked to vulnerability to neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2024.11.003

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 114 · Cited by 34

Authors
Matera, A., Compagnion, A.-C., Pedicone, C., Kotah, J. M., Ivanov, A., Monsorno, K., Labouèbe, G., Leggio, L., Pereira-Iglesias, M., Beule, D., Mansuy-Aubert, V., Williams, T. L., Iraci, N., Sierra, A., Marro, S. G., Goate, A. M., Eggen, B. J. L., Kerr, W. G., & Paolicelli, R. C.
Affiliations
  • University of Lausanne (CH)
  • Icahn School of Medicine at Mount Sinai (US)
  • University Medical Center Groningen (NL)
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
  • University of Catania (IT)
  • University of Cambridge (GB)
  • Ikerbasque (ES)
  • SUNY Upstate Medical University (US)
Corresponding author
Paolicelli, Rosa C.
Venue
Immunity
Publisher
Elsevier BV
Published
2025-01
Volume
58
Issue
1
Pages
197-217.e13
ISSN
1074-7613 (ISSN-L)
OpenAlex
W4405185892
Cited by
34
References
114
Citations by year
2026: 18 · 2025: 16
FWCI
5.30
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • IRIS (submittedVersion, cc-by)
  • SERVAL (Université de Lausanne) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • European Research Council (REMIND 804949)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (PONa3_00136)
  • European Regional Development Fund (PID2022-136698OB-I00)
  • JPB Foundation
  • Ministerio de Ciencia e Innovación
  • Foundation for the National Institutes of Health (U01AG058635, RO1 AG059717)
  • Université de Lausanne
  • National Institutes of Health
  • Eusko Jaurlaritza (PIBA 2020_1_0030, IT1473-22)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Keywords
SHIP1, microglia, synaptic pruning, complement system, hippocampus development, brain development, synaptic remodeling, cognitive impairment, neurodegeneration, Alzheimer's disease risk, iPSC-derived microglia, lipid phosphatase
MeSH terms
Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Alzheimer Disease, Animals, Complement System Proteins, Hippocampus, Mice, Inbred C57BL, Neuronal Plasticity, Synapses, Microglia, Mice, Knockout, Mice, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review